1. Home
  2. HWKN vs XNCR Comparison

HWKN vs XNCR Comparison

Compare HWKN & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

N/A

Current Price

$124.58

Market Cap

2.5B

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$27.91

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HWKN
XNCR
Founded
1938
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
1995
2013

Fundamental Metrics

Financial Performance
Metric
HWKN
XNCR
Price
$124.58
$27.91
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$200.00
$22.33
AVG Volume (30 Days)
108.5K
1.3M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
0.46%
N/A
EPS Growth
N/A
65.36
EPS
1.35
N/A
Revenue
$1,083,696,000.00
$125,576,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
$6.30
$4.80
P/E Ratio
$89.09
N/A
Revenue Growth
11.21
13.65
52 Week Low
$116.05
$7.91
52 Week High
$186.15
$30.61

Technical Indicators

Market Signals
Indicator
HWKN
XNCR
Relative Strength Index (RSI) 42.90 65.43
Support Level $120.87 $11.20
Resistance Level $156.25 $30.61
Average True Range (ATR) 3.99 1.54
MACD 0.40 -0.09
Stochastic Oscillator 43.87 66.83

Price Performance

Historical Comparison
HWKN
XNCR

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: